$GNPX Genprex, Inc. (Nasdaq) Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer https://www.nasdaq.com/press-release/genprex-doses-first-patient-in-acclaim-3-clinical-study-of-reqorsar-immunogene